However, the quantitative HER2 individual gene score component of the RS assay was compared to assessment of HER2 status by FISH in a case–controlled study using specimens from patients identified in the Kaiser Permanente Northern California Cancer Registry. This evidence concerns the gene ERBB2 and cancer.